Trials / Conditions / Dyskinesia, Medication-Induced
Dyskinesia, Medication-Induced
4 registered clinical trials studyying Dyskinesia, Medication-Induced.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia NCT04147949 | VistaGen Therapeutics, Inc. | Phase 2 |
| Completed | Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia NCT05297201 | Celon Pharma SA | Phase 2 |
| Completed | Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) NCT02657681 | Fundación de investigación HM | Phase 2 |
| Completed | Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia NCT00175955 | UCB Pharma | Phase 2 |